Big Pharma’s off-patent drugs lose out in China’s new price-cutting scheme
12 December 2018
In a Battle of Waterloo-style defeat, off-patent drugs from big pharma firms lost major markets in China as the government adopted a novel procurement scheme to slash generic drug costs. But after steep price cuts, local firms aren't considered winners, either.
Impact of ATMP Manufacturing on Process Equipment and Facility Design
12 December 2018
Advanced therapy medicinal products (ATMPs), based on genes, cells, or tissues, are targeted therapies that deliver a therapeutic benefit to a patient-specific population and often treat rare diseases or improve upon existing therapies. Because these products contrast with current biomanufacturing processes for compounds that are synthetically derived (i.e., small molecule) or proteins or peptides expressed by cellular systems (i.e., large-molecule biopharmaceutical), they are often faced with unique manufacturing challenges that must be supported by appropriate facility designs.
Reference pricing in Russia corresponds best practices of price regulation
11 December 2018
Speaking at OECD Competition Committee in Paris, Deputy Head of FAS discussed a set of FAS measures towards reducing the maximum ex-works manufacturer prices registered in Russia for medicine to the minimum prices in the reference countries for Russia.
With pricing outcry raging, U.S. drug spending grew less than 1% last year: CMS
11 December 2018
Congress and the Trump administration are riled up about pharma prices and promising to drive them down, but a new U.S. government report shows growth in retail drug spending screeched to a halt in 2017.
Relay adds executives to its chemistry, R&D teams as it transitions to the development stage
10 December 2018
Former Fierce 15 winner Relay Therapeutics has brought on Verastem’s Mahesh Padval, Ph.D., and Eli Lilly’s Mary Mader, Ph.D., to boost its drug discovery and development operations in oncology as it begins to transition to an R&D-stage biotech.
U.K. sets out digital, data-driven plan to accelerate R&D
10 December 2018
The U.K. government has set out how it plans to use data and digital technologies to attract clinical trials. Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.
Scientists developed the first fully personalized tissue implant
07 December 2018
In a new study, Tel Aviv University (Israel) researchers reveal how they invented the first fully personalized tissue implant, engineered from a patient’s own materials and cells. The new technology makes it possible to engineer any kind of tissue implant from one small fatty tissue biopsy.
Five Russian startups present their projects at Cambridge Biomedical Campus
07 December 2018
Five Russian startups, the winners of the Startup Challenge accelerator, organised jointly by the Skolkovo Foundation and multinational pharma giant AstraZeneca, are showcasing their inventions at the International Future Healthcare Forum in the British city of Cambridge (UK) this week.
Researchers published the study on fractional-dose yellow fever vaccination
06 December 2018
Researchers from Leiden University Medical Center (Leiden, the Netherlands) studied 10 year follow-up data on a subgroup of patients from the trial to evaluate whether fractional-dose vaccination conferred long-term immunity.
Scientists developed new mathematical method for precision medicine
06 December 2018
A research team from MedUni Vienna’s Institute of Medical Statistics (Austria) presented new mathematical methods that efficiently identify the characteristics that are relevant for such predictions. These methods can also be used to calculate the range of statistical variation of these predictions.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Researchers propose novel test for pyrogen detection
27 March 2024
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024